Literature DB >> 16170132

Hydroxyapatite promotes superior keratocyte adhesion and proliferation in comparison with current keratoprosthesis skirt materials.

J S Mehta1, C E Futter, S R Sandeman, R G A F Faragher, K A Hing, K E Tanner, B D S Allan.   

Abstract

AIM: Published clinical series suggest the osteoodontokeratoprosthesis (OOKP) may have a lower extrusion rate than current synthetic keratoprostheses. The OOKP is anchored in the eye wall by autologous tooth. The authors' aim was to compare adhesion, proliferation, and morphology for telomerase transformed keratocytes seeded on calcium hydroxyapatite (the principal mineral constituent of tooth) and materials used in the anchoring elements of commercially available synthetic keratoprostheses.
METHODS: Test materials were hydroxyapatite, polytetrafluoroethylene (PTFE), polyhydroxyethyl methacrylate (HEMA), and glass (control). Cell adhesion and viability were quantified at 4 hours, 24 hours, and 1 week using a calcein-AM/EthD-1 viability/cytotoxicity assay. Focal contact expression and cytoskeletal organisation were studied at 24 hours by confocal microscopy with immunoflourescent labelling. Further studies of cell morphology were performed using light and scanning electron microscopy.
RESULTS: Live cell counts were significantly greater on hydroxyapatite surfaces at each time point (p<0.04). Dead cell counts were significantly higher for PTFE at 7 days (p<0.002). ss(1) integrin expression was highest on hydroxyapatite. Adhesion structures were well expressed in flat, spread out keratocytes on both HA and glass. Keratocytes tended to be thinner and spindle shaped on PTFE. The relatively few keratocytes visible on HEMA test surfaces were rounded and poorly adherent.
CONCLUSIONS: Keratocyte adhesion, spreading, and viability on hydroxyapatite test surfaces is superior to that seen on PTFE and HEMA. Improving the initial cell adhesion environment in the skirt element of keratoprostheses may enhance tissue integration and reduce device failure rates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170132      PMCID: PMC1772890          DOI: 10.1136/bjo.2004.064147

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  28 in total

1.  Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts.

Authors:  F S Wyllie; C J Jones; J W Skinner; M F Haughton; C Wallis; D Wynford-Thomas; R G Faragher; D Kipling
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

Review 2.  Closer to nature: new biomaterials and tissue engineering in ophthalmology.

Authors:  B Allan
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 3.  Function and interactions of integrins.

Authors:  A van der Flier; A Sonnenberg
Journal:  Cell Tissue Res       Date:  2001-09       Impact factor: 5.249

4.  Novel materials to enhance keratoprosthesis integration.

Authors:  S R Sandeman; R G Faragher; M C Allen; C Liu; A W Lloyd
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 5.  Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche.

Authors:  Martin Grueterich; Edgar M Espana; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2003 Nov-Dec       Impact factor: 6.048

6.  A model for the preliminary biological screening of potential keratoprosthetic biomaterials.

Authors:  S R Sandeman; A W Lloyd; B J Tighe; V Franklin; J Li; F Lydon; C S C Liu; D J Mann; S E James; R Martin
Journal:  Biomaterials       Date:  2003-11       Impact factor: 12.479

7.  In vitro differentiation capacity of telomerase immortalized human RPE cells.

Authors:  Lakshmi Rambhatla; Choy-Pik Chiu; Randolph D Glickman; Cheryl Rowe-Rendleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

8.  Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction.

Authors:  James V Jester; Jin Ho-Chang
Journal:  Exp Eye Res       Date:  2003-11       Impact factor: 3.467

9.  Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications.

Authors:  C R Hicks; G J Crawford; X Lou; D T Tan; G R Snibson; G Sutton; N Downie; L Werner; T V Chirila; I J Constable
Journal:  Eye (Lond)       Date:  2003-04       Impact factor: 3.775

10.  Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines.

Authors:  Ilene K Gipson; Sandra Spurr-Michaud; Pablo Argüeso; Ann Tisdale; Tat Fong Ng; Cindy Leigh Russo
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-06       Impact factor: 4.799

View more
  6 in total

1.  PHEMA as a keratoprosthesis material.

Authors:  C R Hicks; T V Chirila; S Vijayasekaran; G J Crawford
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients.

Authors:  E J Hollick; S L Watson; J K G Dart; P J Luthert; B D S Allan
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

3.  Hydroxyapatite for keratoprosthesis biointegration.

Authors:  Liqiang Wang; Kyung Jae Jeong; Homer H Chiang; David Zurakowski; Irmgard Behlau; James Chodosh; Claes H Dohlman; Robert Langer; Daniel S Kohane
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-22       Impact factor: 4.799

Review 4.  Biologic keratoprosthesis materials.

Authors:  Joseph B Ciolino; Claes H Dohlman
Journal:  Int Ophthalmol Clin       Date:  2009

5.  In vitro effect of a corrosive hostile ocular surface on candidate biomaterials for keratoprosthesis skirt.

Authors:  Xiao Wei Tan; Andri Riau; Zhi Long Shi; Anna C S Tan; Koon Gee Neoh; Khiam Aik Khor; Roger W Beuerman; Donald Tan; Jodhbir S Mehta
Journal:  Br J Ophthalmol       Date:  2012-07-16       Impact factor: 4.638

Review 6.  Histopathologic Evaluation of Polymer Supports for Pintucci-type Keratoprostheses: An Animal Study.

Authors:  Saeed Rahmani; Mozhgan Rezaei Kanavi; Mohammad Ali Javadi; Masoumeh Meskinfam Langroudi; Sasha Afsar Aski
Journal:  J Ophthalmic Vis Res       Date:  2019-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.